Cargando…
Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes
α-Glucosidase inhibitors (AGIs) are a class of oral glucose-lowering drugs used exclusively for treatment or prevention of type 2 diabetes mellitus. AGIs act by altering the intestinal absorption of carbohydrates through inhibition of their conversion into simple sugars (monosaccharides) and thus de...
Autores principales: | DiNicolantonio, James J, Bhutani, Jaikrit, O'Keefe, James H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620230/ https://www.ncbi.nlm.nih.gov/pubmed/26512331 http://dx.doi.org/10.1136/openhrt-2015-000327 |
Ejemplares similares
-
Postprandial insulin assay as the earliest biomarker for diagnosing pre-diabetes, type 2 diabetes and increased cardiovascular risk
por: DiNicolantonio, James J, et al.
Publicado: (2017) -
The health benefits of vitamin K
por: DiNicolantonio, James J, et al.
Publicado: (2015) -
Coenzyme Q10 for the treatment of heart failure: a review of the literature
por: DiNicolantonio, James J, et al.
Publicado: (2015) -
Perindopril for improving cardiovascular events
por: DiNicolantonio, James J, et al.
Publicado: (2014) -
Magnesium for the prevention and treatment of cardiovascular disease
por: DiNicolantonio, James J, et al.
Publicado: (2018)